Are insulin sensitivity and β-cell function associated with adverse pregnancy outcomes among women with gestational diabetes?

作     者：Gang Hu Gang Hu

作者机构：Chronic Disease Epidemiology LaboratoryPennington Biomedical Research CenterBaton RougeLA 70808USA 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2022年第135卷第21期

页      面：2521-2524页

核心收录：

学科分类：1002[医学-临床医学] 100211[医学-妇产科学] 10[医学] 

基　　金：supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases(No.R01DK100790) the National Institute of General Medical Sciences(No.U54GM104940)of the National Institutes of Health. 

主　　题：pregnancy mother fetus 

摘      要：Gestational diabetes mellitus(GDM),defined as any degree of glucose intolerance with onset or first recognition during pregnancy,is a common pregnancy outcome.[1]GDM carries risks for the mothers,and fetus,neonate,and childhoodin the offspring.Women with GDM mayincrease risks of high blood pressure and preeclampsia during pregnancy,primary cesarean section,and future obesity,hypertension,dyslipidemia,metabolic syndrome,and cardiovascular disease.